18 results
6-K
EX-99.1
GMAB
Genmab
19 Feb 20
Innovating antibodies, improving lives Annual Report 2019 Genmab A/S CVR No. 21 02 38 84
1:28pm
injuries and illnesses compared with a regional standard average of working days in the year, adjusted for holidays. Management’s Review / Human Capital
6-K
EX-99.1
GMAB
Genmab
14 Feb 24
Genmab 2023 Annual Report
12:30pm
and occupational injuries or illnesses compared with a regional standard average of working days in the year, adjusted for holidays.
Genmab 2023 Annual Report
6-K
EX-99.1
GMAB
Genmab
14 Feb 24
Genmab 2023 Annual Report
12:30pm
leave and occupational injuries or illnesses compared with a regional standard average of working days in the year, adjusted for holidays.
Genmab A/S
Tel
6-K
EX-99.1
GMAB
Genmab
16 Feb 22
Genmab 2021 Annual Report
11:29am
of absence is measured as absence due to the employee’s own illness, pregnancy-related sick leave and occupational injuries and illnesses compared
6-K
EX-99.1
g2t350xrm167wk
23 Feb 21
Genmab 2020 Annual Report
12:38pm
6-K
EX-99.1
068gqhhd0owbw
16 Feb 22
Genmab 2021 Annual Report
11:29am
6-K
EX-99.1
egmbxn9
23 Feb 21
Genmab 2020 Annual Report
12:38pm
DRS/A
z7prcgeqqmr6qv5
13 May 19
Draft registration statement (amended)
12:00am
20-F
jas3618z
30 Mar 20
Annual report (foreign)
5:12pm
F-1/A
hziin73ol43
16 Jul 19
Registration statement (foreign) (amended)
8:05am
DRS
p69neokw 1u
5 Feb 19
Draft registration statement
12:00am
DRS/A
ksxpo1et
2 Apr 19
Draft registration statement (amended)
12:00am
F-1
hkwhckz lklhqb
28 May 19
Registration statement (foreign)
4:27pm
424B4
s9sp97x9x xv
19 Jul 19
Prospectus supplement with pricing info
12:00am
F-1/A
5esnk
9 Jul 19
Registration statement (foreign) (amended)
6:13am
- Prev
- 1
- Next